Cart
sales@molnova.com
Edoxudine
CAS No. 15176-29-1
Edoxudine( Edoxudine | CCRIS 2349 | CCRIS2349 | Edoxudina )
Catalog No. M18060 CAS No. 15176-29-1
Edoxudine, an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 104 | In Stock |
|
| 100MG | 177 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEdoxudine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEdoxudine, an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus.
-
DescriptionEdoxudine, an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus. Edoxudine is used as a 5-fluorouracil (FU) modulator. Edoxudine may be used to enhance the therapeutic index of 5-FU by reducing the catabolism, prolonging the plasma and intratumoral concentrations of 5-FU, and offering protection to normal organs by increasing the endogenous uridine levels. It can also enhance the antitumour action of 5-FU.
-
In Vitro——
-
In Vivo——
-
SynonymsEdoxudine | CCRIS 2349 | CCRIS2349 | Edoxudina
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorAntiviral
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number15176-29-1
-
Formula Weight256.26
-
Molecular FormulaC11H16N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 125 mg/mL; 487.79 mM
-
SMILESCCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O
-
Chemical Name5-Ethyldeoxyuridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kralovanszky, et al. 5-Ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil[J]. Journal of Cancer Research & Clinical Oncology, 1999, 125(12):675-684.
molnova catalog
related products
-
Dazmegrel
Dazmegrel (UK 38,485) is a potent and specific thromboxane A2 (TXA2) synthase inhibitor for the prevention of increased whole platelet aggregation in normal pregnancy.
-
Cevoglitazar
Cevoglitazar (LBM-642) is a PPARɑ agonist and PPARγ agonist. Cevoglitazar potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
-
CGS 15435
CGS 15435 is a potent thromboxen (TxA2) synthetase inhibitor (IC50: 1 nM). CGS 15435 acts on PGI2 synthase, cyclooxygenase and liposynthase with much less selectivity than on thromboxin synthase.
